Molecular Diagnostic Core

分子诊断核心

基本信息

  • 批准号:
    8293258
  • 负责人:
  • 金额:
    $ 14.57万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-07-01 至 2017-06-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY (See instructions): The Molecular Diagnostics Core will support the three major research projects and interact directly with the Database and Biostatistics Core in the organization of an archive of biological material that will be collected during the course ofthe research projects. Core activities include the application of existing methods for identifying parasite and mosquito species and strains by conventional microscopy, current molecular diagnostic methods, and by newly emerging cell biology and DNA sequencing technology. The Specific Aims are to: 1: Create an ICEMR Archive of human blood samples and mosquitoes for characterizing malaria species and strains, and for evaluating immunological parameters of infection by Plasmodium species and clinical malaria 2: Develop PCR-based assays to diagnose Plasmodium species Infections of human study participants and mosquitoes 3: Develop PCR-based assays to diagnose Infection by Plasmodium strains in human study participants and mosquitoes 4: In collaboration with the Transmission Project, develop PCR-based assays to perform mosquito speciation, process mosquitoes for blood meal source and monitor permethrin resistance 5: Develop microscopy- and PCR-based assays to diagnose Plasmodium gametocyte stages in human study participants 6: Evaluate and develop strategies based on advanced DNA sequencing strategies to analyze complexity of Plasmodium species infections and Anopheles mosquito diversity using polymorphisms distributed across the parasite and vector species genomes 7: Build capacity and transfer technology to partner institution laboratories in malaria endemic sites The Molecular Diagnostics Core will be directed by Prof. Zimmerman who has worked with PNGIMR (Mueller), the Swiss Tropical Institute (Felger) and UQ (Cooper and Beebe) on malaria epidemiology and mosquito ecology for >10 years. He will be assisted by I Felger, now at STI and previously an employee of PNGIMR. Capacity building and training in the malaria endemic site will be assured by the continuing high commitment of this team to expanding cost effective technologies to the region covered by the ICEMR.
项目概述(见说明):分子诊断核心将支持三大研究

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PETER A. ZIMMERMAN其他文献

PETER A. ZIMMERMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PETER A. ZIMMERMAN', 18)}}的其他基金

Madagascar P. vivax Invasion of Duffy-negative Red Cells
马达加斯加间日疟原虫入侵达菲阴性红细胞
  • 批准号:
    9121464
  • 财政年份:
    2013
  • 资助金额:
    $ 14.57万
  • 项目类别:
W. bancrofti infection diversity and treatment response
班克罗夫蒂W. bancrofti感染多样性和治疗反应
  • 批准号:
    8426737
  • 财政年份:
    2013
  • 资助金额:
    $ 14.57万
  • 项目类别:
Madagascar P. vivax Invasion of Duffy-negative Red Cells
马达加斯加间日疟原虫入侵达菲阴性红细胞
  • 批准号:
    8731173
  • 财政年份:
    2013
  • 资助金额:
    $ 14.57万
  • 项目类别:
Madagascar P. vivax Invasion of Duffy-negative Red Cells
马达加斯加间日疟原虫入侵达菲阴性红细胞
  • 批准号:
    8900911
  • 财政年份:
    2013
  • 资助金额:
    $ 14.57万
  • 项目类别:
W. bancrofti infection diversity and treatment response
班克罗夫蒂W. bancrofti感染多样性和治疗反应
  • 批准号:
    8722428
  • 财政年份:
    2013
  • 资助金额:
    $ 14.57万
  • 项目类别:
Madagascar P. vivax Invasion of Duffy-negative Red Cells
马达加斯加间日疟原虫入侵达菲阴性红细胞
  • 批准号:
    8501953
  • 财政年份:
    2013
  • 资助金额:
    $ 14.57万
  • 项目类别:
Molecular Diagnostic Core
分子诊断核心
  • 批准号:
    8494549
  • 财政年份:
    2013
  • 资助金额:
    $ 14.57万
  • 项目类别:
Whole genome sequencing of Malagasy Duffy-independent P. vivax
马达加斯加非达菲依赖性间日疟原虫的全基因组测序
  • 批准号:
    8230462
  • 财政年份:
    2011
  • 资助金额:
    $ 14.57万
  • 项目类别:
Whole genome sequencing of Malagasy Duffy-independent P. vivax
马达加斯加非达菲依赖性间日疟原虫的全基因组测序
  • 批准号:
    8088479
  • 财政年份:
    2011
  • 资助金额:
    $ 14.57万
  • 项目类别:
Molecular Diagnostic Core
分子诊断核心
  • 批准号:
    8009105
  • 财政年份:
    2010
  • 资助金额:
    $ 14.57万
  • 项目类别:

相似海外基金

ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
  • 批准号:
    10935820
  • 财政年份:
    2023
  • 资助金额:
    $ 14.57万
  • 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
  • 批准号:
    10932514
  • 财政年份:
    2023
  • 资助金额:
    $ 14.57万
  • 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
  • 批准号:
    10704845
  • 财政年份:
    2023
  • 资助金额:
    $ 14.57万
  • 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
  • 批准号:
    10709085
  • 财政年份:
    2023
  • 资助金额:
    $ 14.57万
  • 项目类别:
Advanced Development of Gemini-DHAP
Gemini-DHAP的高级开发
  • 批准号:
    10760050
  • 财政年份:
    2023
  • 资助金额:
    $ 14.57万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10409385
  • 财政年份:
    2022
  • 资助金额:
    $ 14.57万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10710595
  • 财政年份:
    2022
  • 资助金额:
    $ 14.57万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10630975
  • 财政年份:
    2022
  • 资助金额:
    $ 14.57万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
  • 批准号:
    10710588
  • 财政年份:
    2022
  • 资助金额:
    $ 14.57万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10788051
  • 财政年份:
    2022
  • 资助金额:
    $ 14.57万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了